Chief Corporate Development Officer
Kristen Slaoui is Chief Corporate Development Officer since September 2020.
Kristen joined from GlaxoSmithKline where she was Vice President and Head of Business Development for the Global Pharmaceuticals Commercial Portfolio. She spent twenty years with GSK, first as a principal scientist in R&D before joining the Business Development team in 2006 where she held various roles of increasing seniority and executed transactions covering the pharma R&D, commercial, emerging markets, specialty pharma and consumer spaces. From 2010-2015, she was the Vice President and Head of Business Development for Stiefel, a GSK company - GSK’s wholly owned dermatology division.
Kristen has bachelor’s degrees in both Biology and Classical Studies from Gettysburg College, a Ph.D. in Physiology from The Johns Hopkins University Bloomberg School of Public Health and has completed an NIH Post-Doctoral Fellowship at the University of Washington in Seattle, Washington.